Pressrelease 7 February 2006
Positive Results from the First Time in Animal Study
Glucox Biotech today announces positive results from the First Time In Animal study (FTIA) in mice, showing a tolerance of the company’s lead drug GLX010 in these animals. This finding is an important step forward for the company and is in line with the intended proceedings in developing an oral drug as a future treatment of non-insulin dependant Diabetes Mellitus.
Download a pdf of the Pressrelease
Pressrelease 15 May 2007
Promising Results in Treatment with GLX
Pressrelease 29 December 2006
US Patent Received for Diabetes Treatment
Pressrelease 28 September 2006
Glucox' Unique Research Discovery Confirmed by US Scientist
Pressrelease 10 July 2006
Patent Application Submitted for the GLX Compounds
Pressrelease 5 June 2006
A Significant Preclinical Milestone Achieved
Pressrelease 7 February 2006
Positive Results from the First Time In Animal Study
Pressrelease 10 January 2006
Pressrelease 10 November 2005
Evaluation and Selection of Glucox Biotech' Lead Drug Candidates